March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Get basic information on some common complementary therapies. Learn which ones can help and which ones may be harmful for HIV+ people.
Get information on what you need to know before you get pregnant, HIV drugs during pregnancy, what happens after the baby is born, and more.